மருந்து கட்டுப்பாடு ஜநரல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து கட்டுப்பாடு ஜநரல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து கட்டுப்பாடு ஜநரல் Today - Breaking & Trending Today

COVID-19: Maharashtra govt refuses to float global tender for vaccine, says will try and augment supplies through Centre, vaccine manufacturers


: Thursday, May 13, 2021, 11:11 PM IST
COVID-19: Maharashtra govt refuses to float global tender for vaccine, says will try and augment supplies through Centre, vaccine manufacturers
(Photo by AFP)
Even as the BrihanMumbai Municipal Corporation (BMC) floated a global tender to procure 1 crore COVID 19 vaccines, the Maharashtra Government has dropped its plan to follow suit, citing procedural, legal and clinical issues.
Instead, the state government will press the Centre for additional supply of vaccines; as well as pursue the matter with the manufacturers, Serum Institute of India and Bharat Biotech.
The state government has also sent mails to the Russian Direct Investment Fund and its Indian partner Dr Reddy’s Laboratories for procurement of Sputnik V but it is yet to receive responses from them. ....

Uddhav Thackeray , Free Press Journal , Brihanmumbai Municipal Corporation , Indian Council Of Medical Research , Serum Institute Of India , Russian Direct Investment Fund , Maharashtra Government , Serum Institute , Chief Minister Uddhav Thackeray , Drug Control General , Indian Council , Medical Research , Covid 19 , உத்தவ் தாக்கரே , இலவசம் ப்ரெஸ் இதழ் , ப்ரிஹுன்மும்பை நகராட்சி நிறுவனம் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , சீரம் நிறுவனம் ஆஃப் இந்தியா , ரஷ்ய நேரடி முதலீடு நிதி , மகாராஷ்டிரா அரசு , சீரம் நிறுவனம் , தலைமை அமைச்சர் உத்தவ் தாக்கரே , மருந்து கட்டுப்பாடு ஜநரல் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி ,

DCGI approves new anti-Covid drug developed by DRDO for emergency use


DCGI approves new anti-Covid drug developed by DRDO for emergency use
May 08, 2021
In 2-DG arm, indications of early relief from Oxygen therapy/dependence
A new drug developed by the Defence Research and Development Organisation (DRDO) in association with Dr Reddy’s Laboratories Ltd has been approved for emergency use in the treatment of Covid-19 patients by the Drug Control General of India (DCGI).
An anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
“Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients. The drug will be of immense benefit to the people suffering from Covid-19 in the on ....

Andhra Pradesh , Tamil Nadu , Centre For Cellular , Institute Of Nuclear Medicine , Central Drugs Standard Control Organization , Development Organisation , Dr Reddy Laboratories Ltd , Defence Research , Laboratories Ltd , Drug Control General , Nuclear Medicine , Allied Sciences , Molecular Biology , Drugs Controller General , West Bengal , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , மையம் க்கு செல்லுலார் , நிறுவனம் ஆஃப் அணு மருந்து , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , வளர்ச்சி ஆர்கநைஸேஶந் , டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட் , பாதுகாப்பு ஆராய்ச்சி , ஆய்வகங்கள் லிமிடெட் , மருந்து கட்டுப்பாடு ஜநரல் , அணு மருந்து ,

Covid-19: India to ramp up Remdesivir production to 78 lakh vials a month

Covid-19: India to ramp up Remdesivir production to 78 lakh vials a month
thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.

Mansukh Mandaviya , Drug Control General , மன்சுக் மண்டவியா , மருந்து கட்டுப்பாடு ஜநரல் ,

Thermo Fisher to make COVID-19 RT-PCR testing kits in Bengaluru


Thermo Fisher to make COVID-19 RT-PCR testing kits in Bengaluru
Coronavirus in India: The new facility will have a capacity to manufacture up to 10 million tests every month. CoviPath COVID-19 RT-PCR Kit has been approved by the ICMR and DCGI
PB Jayakumar | February 17, 2021 | Updated 10:14 IST
Thermo Fisher to make coronavirus test kits in India
Thermo Fisher Scientific, one of the leading global medical devices manufacturers, will produce COVID-19 testing kits and diagnostic solutions at its manufacturing facility in Bengaluru for the Indian market. 
The new facility will have a capacity to manufacture up to 10 million tests every month. This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards, said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific. ....

Ramit Chopra , Takara Bio , Indian Council For Medical Research , Thermo Fisher , Promega Corporation , Thermo Fisher Scientific , South Asia , Indian Council , Medical Research , Drug Control General , Kapil Sood , Fisher Scientific , Covid 19 Vaccination In India , Vaccination For Covid 19 , Covid 19 Vaccination , Covid 19 Vaccination Programme , Covid 19 Vaccine , Vaccination In India , Covid Vaccination , Covid Vaccine , Covid 19 Vaccine Latest Update , Covishield Vaccine , Covaxin Vaccine , Pm Narendra , அமித் சோப்ரா , தகர உயிர் ,